ReShape Lifesciences(TM) Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation(TM) Device at ObesityWeek® PressReach · Nov 4, 2022
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM) PressReach · Nov 4, 2022
Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022 PressReach · Nov 4, 2022
Allergan Aesthetics Reaffirms Commitment to Breast Health Advocacy with Yearlong Program for Breast Cancer Awareness PressReach · Nov 3, 2022
Publication Recommends OGM for Analysis of Hematological Neoplasms Due to Streamlined Structural Variant Detection and High Concordance with Traditional Cytogenetic Methods PressReach · Nov 3, 2022
Allergan Aesthetics Celebrates Fourth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day PressReach · Nov 2, 2022
Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination PressReach · Nov 2, 2022